Assistant Professor
School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
Dr Chui is an Assistant Professor jointly appointed by the School of Nursing and School of Public Health at HKU. She is an epidemiologist by training and is specialized in applying new observational study design in medication safety research with the use of Big Data. She obtained her PhD degree from the Department of Pharmacology and Pharmacy at HKU in 2017. She was a visiting scholar at the London School of Hygiene and Tropical Medicines in United Kingdom. She completed her post-doctoral training in the School of Public Health at HKU in 2019. Dr Chui is one of the lead researchers in the COVID-19 Vaccines Adverse Events Response and Evaluation (CARE) Programme, a comprehensive surveillance programme to monitor known and potential adverse events of COVID-19 vaccines. She is also a Co-principal investigator of AI and Pharmaceuticals in Non-Communicable Diseases at the Laboratory of Data Discovery for Health (D²4H), the convener and active member of NeuroGEN (Neurological and Mental Health Global Epidemiology Network).
Dr Chui aims to utilize Big Data from multi-regional/national large healthcare databases and that collected in the community to improve public health through implementation science. Her current research focuses on improving cardiovascular disease management and services through machine-learning (ML) driven risk prediction, Big Data for antimicrobial resistance surveillance, and improving care of people living with dementia. She has published more than 100 articles in peer-reviewed journals such as The Lancet Infectious Disease, JAMA Internal Medicine, BMJ, Journal of the American College of Cardiology, and Neurology.